Marco Taglietti, Scynexis CEO

‘Say no more’ to yeast in­fec­tions: Scynex­is rolls out new Brex­afemme mar­ket­ing — and ral­ly­ing cry

Scynex­is is rolling out a new cam­paign for its Brex­afemme yeast in­fec­tion treat­ment, but the ef­fort is more than just ad­ver­tis­ing.

As CEO Mar­co Tagli­et­ti said in wrap­ping his pre­pared com­ments dur­ing an earn­ings call on Thurs­day, “Let me fin­ish with our new ral­ly­ing cry — yeast in­fec­tion, say no more.”

That head­line — writ­ten as “Yeast in­fec­tion? Say no more” — ap­pears on Scynex­is’ re­cent­ly launched ad cam­paign to health­care providers and will be­gin rolling out to con­sumers lat­er this month.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.